iShares, the world’s largest provider of exchange trade funds, filed paperwork with the Securities and Exchange Commission to market three actively managed equity ETFs focused on broad market sectors.
iShares didn’t release tickers or expense ratios in its filings. The names of the three funds and the links to their filings are as follows:
The three proposed iShares funds speak to a growing interest on the part of ETF sponsors to market funds with higher returns in the current uncertain environment. That’s true of indexed ETF strategies using “smart beta” screens, just as the three proposed "strategic beta" iShares ETFs will use actual managers to select funds deemed to have superior potential for returns.
All the three new iShares funds take definable categories of stocks and then whittle them down by means of rules-based screens to emphasize stocks with higher quality earnings, lower relative valuations, and smaller market capitalizations, while eschewing those that lack those qualities.
Within their respective categories, the funds all target the same broad base of sectors that include discretionary consumer spending, financial and industrial companies.
Being actively managed, these funds typically will have a higher portfolio turnover than funds that seek to replicate the performance of an index, the filing said.
Under normal circumstances the funds will invest at least 80 percent of their net assets in equity securities comprising their respective investment categories: U.S. large cap, U.S. small cap, and international small cap.
The filing said that the funds will invest in currency forwards for hedging or trade-settlement purposes.
iShares said it reserves the right to lend up to one-third of the assets of each one of these funds, and the company noted, securities lending involves the risk that the funds may lose money because the borrower may fail to return the securities in a timely manner or at all.
In addition, according to the filings, were this type of event to occur, it could trigger negative tax consequences.
It's easy to be blinded by headline numbers. The rally in biotech isn't so simple.
A low-volatility emerging markets ETF outpaces its plain-vanilla counterpart as it marks its three-year anniversary.
It may have been inadvertent, but the SEC’s ruling to block nontransparent active ETFs is a real plus for investors.
Knowing what ‘yield’ even means is a crucial requirement for ETF investors.